UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1873-1880

2000

Volltextzugriff (PDF)

Computer-Aided Selection of Potential Antihypertensive Compounds with Dual Mechanism of Action

Journal of medicinal chemistry, 2003-07, Vol.46 (15), p.3326-3332

2003

Volltextzugriff (PDF)

Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)

Leukemia research, 1999-05, Vol.23 (5), p.499-505

1999

Volltextzugriff (PDF)

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

Journal of clinical immunology, 2000-05, Vol.20 (3), p.195-202

2000

Volltextzugriff (PDF)

Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms

Medicinal Chemistry Reviews - Online, 2005-12, Vol.2 (6), p.447-454

2005

Volltextzugriff (PDF)

Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers

Current medicinal chemistry, 2006-08, Vol.13 (20), p.2345-2352

2006

Volltextzugriff (PDF)

Effect of vaccination of leukemia patients with a MHC class I peptide of Wilms tumor gene 1 (WT1) peptide with unspecific T helper stimulation on WT1-specific IgM responses and on IgG responses

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3054-3054

2008

Volltextzugriff (PDF)

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

Immunogenetics (New York), 2000-02, Vol.51 (2), p.99-107

2000

Volltextzugriff (PDF)

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Blood, 2002-05, Vol.99 (9), p.3272-3279

2002

Volltextzugriff (PDF)

Identification and Characterization of a WT1 (Wilms Tumor Gene) Protein-derived HLA-DRB10405-restricted 16-mer Helper Peptide That Promotes the Induction and Activation of WTi-specific Cytotoxic T Lymphocytes

Journal of immunotherapy, 2007-04, Vol.30 (3), p.282-293

2007

Volltextzugriff (PDF)

Induction of WT1 (Wilms' Tumor Gene)-Specific Cytotoxic T Lymphocytes by WT1 Peptide Vaccine and the Resultant Cancer Regression

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (38), p.13885-13890

2004

Volltextzugriff (PDF)

Influence of NaCl on the Behavior of PEO−PPO−PEO Triblock Copolymers in Solution, at Interfaces, and in Asymmetric Liquid Films

Langmuir, 2005-05, Vol.21 (11), p.4954-4963

2005

Volltextzugriff (PDF)

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Leukemia, 2012, Vol.26 (6), p.1410-1413

2012

Volltextzugriff (PDF)

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Leukemia, 2012-06, Vol.26 (6), p.1410-1413

2012

Volltextzugriff (PDF)

Novel electrochemical approach to study corrosion mechanism of Al-Au wire-bond pad interconnections

Corrosion engineering, science and technology, 2013-09, Vol.48 (6), p.409-417

2013

Volltextzugriff (PDF)

Potentiodynamic anodizing of aluminum alloys in Cr(VI)-free electrolytes

Surface and interface analysis, 2016-08, Vol.48 (8), p.946-952

2016

Volltextzugriff (PDF)

Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype

Biochemistry (Moscow), 1999-04, Vol.64 (4), p.448-455

1999

Volltextzugriff (PDF)

Th1-biased humoral immune responses against wilms tumor gene WT1 product in the patients with hematopoietic malignancies

Leukemia, 2005-02, Vol.19 (2), p.268-274

2005

Volltextzugriff (PDF)

Thinning of wetting films formed from aqueous solutions of non-ionic surfactant

Journal of colloid and interface science, 2006-09, Vol.301 (1), p.210-216

2006

Volltextzugriff (PDF)

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

International journal of hematology, 2003-07, Vol.78 (1), p.56-61

2003

Volltextzugriff (PDF)

WT1 as a novel target antigen for cancer immunotherapy

Current cancer drug targets, 2002-03, Vol.2 (1), p.45-54

2002

Volltextzugriff (PDF)

WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

Microbiology and immunology, 2004-01, Vol.48 (3), p.175-184

2004

Volltextzugriff (PDF)

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Cancer Immunology, Immunotherapy, 2004-07, Vol.53 (7), p.617-624

2004

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)
Berichte
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(14)
Humans
(13)
Immunotherapy
(8)
Wt1 Proteins - Immunology
(8)
Animals
(7)
Biological And Medical Sciences
(7)
Wt1
(7)
Immunology
(6)
Leukemia
(6)
Male
(6)
Medical Sciences
(6)
Peptide Fragments - Immunology
(6)
Female
(5)
Hematology
(5)
Mice
(5)
Oncology
(5)
T-Lymphocytes, Cytotoxic - Immunology
(5)
Tumors
(5)
Wilms' Tumor Gene
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product

Computer-Aided Selection of Potential Antihypertensive Compounds with Dual Mechanism of Action

Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms

Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers

Effect of vaccination of leukemia patients with a MHC class I peptide of Wilms tumor gene 1 (WT1) peptide with unspecific T helper stimulation on WT1-specific IgM responses and on IgG responses

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Identification and Characterization of a WT1 (Wilms Tumor Gene) Protein-derived HLA-DRB10405-restricted 16-mer Helper Peptide That Promotes the Induction and Activation of WTi-specific Cytotoxic T Lymphocytes

Induction of WT1 (Wilms' Tumor Gene)-Specific Cytotoxic T Lymphocytes by WT1 Peptide Vaccine and the Resultant Cancer Regression

Influence of NaCl on the Behavior of PEO−PPO−PEO Triblock Copolymers in Solution, at Interfaces, and in Asymmetric Liquid Films

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Novel electrochemical approach to study corrosion mechanism of Al-Au wire-bond pad interconnections

Potentiodynamic anodizing of aluminum alloys in Cr(VI)-free electrolytes

Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype

Th1-biased humoral immune responses against wilms tumor gene WT1 product in the patients with hematopoietic malignancies

Thinning of wetting films formed from aqueous solutions of non-ionic surfactant

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

WT1 as a novel target antigen for cancer immunotherapy

WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Suchergebnisse filtern